Executive Insights

Dymicron shares how its Triadyme-C is engineered to reduce wear debris and mimic the natural kinematics and motion of a...

Bioretec’s strategy involves significantly expanding its presence in the U.S. and advancing its implant materials for new indications. ...

Selected comments from the leaders of top orthopedic companies as they reported second quarter 2025 earnings....

We spoke with Eric Tamweber, Stryker’s Vice President and General Manager of Trauma, about the culture and innovation driving its...

Excerpts from OMTEC 2025's keynote panel discussing issues and opportunities impacting orthopedic manufacturing....

Smaller European and Asian companies have shown interest in the U.S. and markets outside of their headquarter region. Citieffe is...

Selected comments from the leaders of top orthopedic companies as they reported first quarter 2025 earnings....

Materialise's CEO says surgeons and industry see advantages with patient-specific instrumentation and implants and pre-operative planning....

Kuros Biosciences believes data will give the company a strategic edge as it builds out its product portfolio and enters...

LINK has experienced significant growth since building out its portfolio of primary knee, hip and shoulder implants....